BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1419 related articles for article (PubMed ID: 25884842)

  • 1. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.
    Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T
    Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA
    Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
    Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
    Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.
    Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA
    Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
    Parris AB; Zhao Q; Howard EW; Zhao M; Ma Z; Yang X
    J Exp Clin Cancer Res; 2017 Feb; 36(1):28. PubMed ID: 28193239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.
    Ning X; Du Y; Ben Q; Huang L; He X; Gong Y; Gao J; Wu H; Man X; Jin J; Xu M; Li Z
    Cell Cycle; 2016; 15(3):403-12. PubMed ID: 26709750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization.
    Gatti M; Wurth R; Vito G; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Villa V; Corsaro A; Nizzari M; Bajetto A; Ratto A; Ferrari A; Barbieri F; Florio T
    Jpn J Vet Res; 2016 May; 64(2):101-12. PubMed ID: 27506084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.
    Huang J; Zhang D; Xie F; Lin D
    J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
    Torres CG; Olivares A; Stoore C
    Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.